<html>

        <head>
        <link href="../style1.css" rel="stylesheet" type="text/css">
        </head>
        <table border = 1>
        <tr>
        <th>PubMedID</th>
        <th>Sentence</th>
        <th>First Gene</th>
        <th>Second Gene</th>
        <th>Interaction</th>
        </tr>
        <body>
<tr class = "cellcolor">
<td>24292625</td>
<td>Using quantitative proteomics, we found that lenalidomide causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase</td>
<td>IKZF1</td>
<td>IKZF3</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24292625</td>
<td>IKZF1 and IKZF3 are essential transcription factors in multiple myeloma</td>
<td>IKZF1</td>
<td>IKZF3</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24292623</td>
<td>Here, we show that lenalidomide-bound cereblon acquires the ability to target for proteasomal degradation two specific B cell transcription factors, Ikaros family zinc finger  proteins- 1 and -3 (IKZF1 and IKZF3)</td>
<td>IKZF1</td>
<td>IKZF3</td>
<td>None</td>
</tr>
<tr class = "cellcolor">
<td>24292623</td>
<td>Analysis of myeloma cell lines revealed that loss of IKZF1 and IKZF3 is both necessary and sufficient for lenalidomide's  therapeutic effect, suggesting that the antitumor and teratogenic activities of thalidomide-like drugs are dissociable.</td>
<td>IKZF1</td>
<td>IKZF3</td>
<td>None</td>
</tr>
